Somatic Genetic Testing Market Expansion Outlook: $13.13 Billion by 2029 Forecast

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Somatic Genetic Testing Market From 2025 To 2034?

The somatic genetic testing market has experienced rapid expansion over recent years. This market is projected to expand from $6.81 billion in 2024 to $7.78 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 14.3%. Historically, this growth has been driven by increased recognition of genetic diseases, the growing incidence of cancer, greater use of genetic testing in medical facilities, enhancements in healthcare infrastructure, and escalating patient requests for tailored treatment options.

The market for somatic genetic testing is projected to expand significantly over the coming years, anticipated to reach a valuation of $13.13 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.0%. Key factors driving this expansion during the forecast period include a heightened focus on early disease identification, an increase in partnerships between biotechnology and pharmaceutical firms, the emergence of more public-private alliances, and the wider availability of diagnostic instruments. Significant trends anticipated during this period encompass advancements in sequencing technology, breakthroughs in bioinformatics and artificial intelligence, increased investment in research and development, the creation of non-invasive testing approaches, and innovations within next-generation sequencing platforms.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp

What Are The Drivers Pushing New Developments In The Somatic Genetic Testing Market?

The anticipated rise in cancer cases is poised to boost the expansion of the somatic genetic testing market in the future. Cancer encompasses various conditions marked by the unrestrained proliferation and dissemination of atypical cells throughout the body. This growing burden of cancer is attributed to lifestyle factors including inadequate diet, tobacco use, lack of physical activity, and heavy alcohol intake. Somatic genetic testing assists in identifying cancer by pinpointing genetic mutations specific to tumors, which facilitates tailored and individualized therapeutic strategies. Furthermore, it reduces the need for invasive procedures through the application of sophisticated technologies, thereby enhancing diagnostic precision and patient recovery. As an illustration, data from the Australian Institute of Health and Welfare, an Australia-based government entity, indicated in July 2024 that Australia recorded 160,570 new cancer diagnoses in 2022, representing an uptick of 3,789 cases from the 156,781 reported in 2021. Consequently, the expanding occurrence of cancer is a key catalyst for the growth within the somatic genetic testing market.

What Are The Major Segments Identified In The Somatic Genetic Testing Market?

The somatic genetic testing market covered in this report is segmented

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Carrier Screening, Other Testing Methods

2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples

3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies

4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Inherited Genetic Disorders, Other Applications

5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, At-Home Testing Providers, Other End-Users

Subsegments:

1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels

2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing

3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing

4) By Carrier Screening: Expanded Carrier Screening, Ethnicity-Based Carrier Screening, Universal Carrier Screening

5) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

Which Key Trends Are Expected To Influence The Somatic Genetic Testing Market In The Coming Years?

Major companies operating in the somatic genetic testing market are dedicating efforts to develop advanced diagnostic solutions, including liquid biopsy tests, to enhance accuracy, enable early detection, and lessen the need for invasive procedures. Liquid biopsy tests are non-invasive techniques that analyze circulating tumor DNA (ctDNA) or other biological indicators in blood samples to identify genetic mutations linked to cancer. As an example, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics firm, launched the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a cutting-edge liquid biopsy designed to detect circulating tumor DNA (ctDNA) from blood samples. The SA74-LB is a comprehensive next-generation sequencing (NGS)-based test crafted to identify somatic mutations across 74 crucial cancer-related genes. This test contributes to personalized cancer treatment by pinpointing actionable mutations, monitoring therapy response, and uncovering minimal residual disease (MRD) without requiring traditional tissue biopsies. It supports precision oncology, aiding in guiding targeted therapies and observing disease progression or resistance instantaneously.

Which Global Market Leaders Are Shaping The Future Of The Somatic Genetic Testing Sector?

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., and Circulogene Theranostics LLC.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report

Which Regional Markets Are Contributing Most To The Somatic Genetic Testing Industry Expansion?

North America was the largest region in the somatic genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Somatic Genetic Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27421&type=smp

Browse Through More Reports Similar to the Global Somatic Genetic Testing Market 2025, By The Business Research Company

Smart Workplace Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-workplace-global-market-report

Office Automation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/office-automation-global-market-report

Smart Windows Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-windows-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795